Cargando…
Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
[Figure: see text]
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917268/ https://www.ncbi.nlm.nih.gov/pubmed/35317050 http://dx.doi.org/10.1016/j.omtm.2022.02.003 |
_version_ | 1784668511422906368 |
---|---|
author | de Marco, Ario Barile, Lucio |
author_facet | de Marco, Ario Barile, Lucio |
author_sort | de Marco, Ario |
collection | PubMed |
description | [Figure: see text] |
format | Online Article Text |
id | pubmed-8917268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-89172682022-03-21 Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles de Marco, Ario Barile, Lucio Mol Ther Methods Clin Dev Editorial [Figure: see text] American Society of Gene & Cell Therapy 2022-03-09 /pmc/articles/PMC8917268/ /pubmed/35317050 http://dx.doi.org/10.1016/j.omtm.2022.02.003 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Editorial de Marco, Ario Barile, Lucio Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles |
title | Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles |
title_full | Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles |
title_fullStr | Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles |
title_full_unstemmed | Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles |
title_short | Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles |
title_sort | good reasons for targeting sars-cov-2 by engineered extracellular vesicles |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917268/ https://www.ncbi.nlm.nih.gov/pubmed/35317050 http://dx.doi.org/10.1016/j.omtm.2022.02.003 |
work_keys_str_mv | AT demarcoario goodreasonsfortargetingsarscov2byengineeredextracellularvesicles AT barilelucio goodreasonsfortargetingsarscov2byengineeredextracellularvesicles |